Since its global invasion in 2019, COVID-19 has affected several aspects of patients' lives
and posed a significant impact on the health care system. Several patient populations were …

A type-2 immune response usually sustains wheezing and asthma in children. In addition,
dysbiosis of digestive and respiratory tracts is detectable in patients with wheezing and …

Some comorbidities are associated with severe coronavirus disease (Covid-19) but it is
unclear whether some increase susceptibility to Covid-19. In this case-control Mexican study …

Background Early-life respiratory tract infections might affect chronic obstructive respiratory
diseases, but conclusive studies from general populations are lacking. Our objective was to …

Background. Type‐2 inflammation commonly marks asthma in childhood. Also, gut and lung
dysbiosis is detectable in patients with asthma. Strain‐related probiotic supplementation …

Lung group 2 innate lymphoid cells (ILC2s) control the nature of immune responses to
airway allergens. Some microbial products, including those that stimulate interferons, block …

Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by severe
acute respiratory syndrome coronavirus SARS-COV-2. Aberrant innate immunity response …

Background Over many years, OM-85, a lysate of 21 common bacterial respiratory
pathogens, has been demonstrated to prevent respiratory recurrences in children. However …

Background Asthma is a complex disease with multiple phenotypes that may differ in
disease pathobiology and treatment response. IL33 single nucleotide polymorphisms …

Background Asthma is a frequently occurring respiratory disease with an increasing
incidence around the world. Airway inflammation and remodeling are important contributors …